JPWO2010098421A1 - 改善された保存安定性を有する組換えヒト骨形成蛋白質 - Google Patents

改善された保存安定性を有する組換えヒト骨形成蛋白質 Download PDF

Info

Publication number
JPWO2010098421A1
JPWO2010098421A1 JP2011501656A JP2011501656A JPWO2010098421A1 JP WO2010098421 A1 JPWO2010098421 A1 JP WO2010098421A1 JP 2011501656 A JP2011501656 A JP 2011501656A JP 2011501656 A JP2011501656 A JP 2011501656A JP WO2010098421 A1 JPWO2010098421 A1 JP WO2010098421A1
Authority
JP
Japan
Prior art keywords
bmp
recombinant human
hydrochloric acid
morphogenetic protein
bone morphogenetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011501656A
Other languages
English (en)
Japanese (ja)
Inventor
昌宏 長屋
昌宏 長屋
和茂 洲鎌
和茂 洲鎌
ジーバルト ウォルター
ジーバルト ウォルター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osteopharma Inc
Original Assignee
Osteopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteopharma Inc filed Critical Osteopharma Inc
Publication of JPWO2010098421A1 publication Critical patent/JPWO2010098421A1/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
JP2011501656A 2009-02-27 2010-02-26 改善された保存安定性を有する組換えヒト骨形成蛋白質 Withdrawn JPWO2010098421A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009047176 2009-02-27
JP2009047176 2009-02-27
PCT/JP2010/053028 WO2010098421A1 (fr) 2009-02-27 2010-02-26 Protéine osseuse morphogénétique humaine recombinante présentant une stabilité au stockage améliorée

Publications (1)

Publication Number Publication Date
JPWO2010098421A1 true JPWO2010098421A1 (ja) 2012-09-06

Family

ID=42665625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011501656A Withdrawn JPWO2010098421A1 (ja) 2009-02-27 2010-02-26 改善された保存安定性を有する組換えヒト骨形成蛋白質

Country Status (2)

Country Link
JP (1) JPWO2010098421A1 (fr)
WO (1) WO2010098421A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110382523B (zh) 2016-12-30 2024-04-16 博晟生医股份有限公司 重组多肽及其组合物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10059336A1 (de) * 2000-11-29 2002-06-13 Scil Proteins Gmbh Herstellung von rekombinantem BMP-2
EP1462126A1 (fr) * 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Matériaux ostéoinductifs améliorés
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations

Also Published As

Publication number Publication date
WO2010098421A1 (fr) 2010-09-02

Similar Documents

Publication Publication Date Title
Lee et al. Gel scaffolds of BMP‐2‐binding peptide amphiphile nanofibers for spinal arthrodesis
US7241740B2 (en) Peptides as solubilizing excipients for transforming growth factor beta proteins
US7163920B2 (en) Peptide with osteogenic activity
JP5529754B2 (ja) Ｎｏｇｇｉｎに対する感受性が低下したＢＭＰ変異体
ES2242630T3 (es) Proteina monomera de la familia tgf-beta.
CN101835493A (zh) 两亲性聚合物和属于bmp家族的成骨蛋白之间的复合物
JP2012082180A (ja) 骨再生用自己組織化ペプチドハイドロゲル
CA2627370C (fr) Mutants d'un facteur de croissance ayant une activite elevee
JP2022520139A (ja) β－リン酸三カルシウム結合配列を含むポリペプチドとその使用
WO2012029148A1 (fr) Préparation cryodesséchée de protéine morphogénétique osseuse humaine recombinante 2
WO2019094938A2 (fr) Méthodes et compositions pour le traitement des plaies
TW201302217A (zh) Ｆｇｆ－１８之凍乾調配物
JP2013518808A (ja) 骨形成タンパク質のｐＨを制御するための緩衝液
US20090291113A1 (en) Osteogenic composition comprising a growth factor, a soluble cation salt and organic support
WO2010098421A1 (fr) Protéine osseuse morphogénétique humaine recombinante présentant une stabilité au stockage améliorée
Chen et al. Fabricating a novel HLC-hBMP2 fusion protein for the treatment of bone defects
Gromov et al. Recombinant human bone growth factor BMP-2 produced in Escherichia coli. Part 1: from protein purification to experimental models for efficacy research
JP2013514811A (ja) 免疫原性が抑制されたｂｍｐ−７変異体
CN110665060A (zh) 一种骨修复材料及其制备方法和应用
Curry et al. Addition of an oligoglutamate domain to bone morphogenic protein 2 confers binding to hydroxyapatite materials and induces osteoblastic signaling
Curry Bmp2-Derived Molecules For Increasing Osteoinductivity Of Bone Grafts To Enhance Bone Regeneration
WO2021087561A1 (fr) Protéines de fusion de cytokine ou de facteur de croissance
JP2024006681A (ja) 生体材料
이재천 Exploring and evaluating scaffolds for in-vivo application of TAT-BMP

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20130507